Morgan Stanley Reiterates Equal-Weight Rating on Onyx Pharmaceuticals on ... Benzinga Morgan Stanley noted, “Addition of Kyprolis to National Comprehensive Cancer Network or NCCN treatment guidelines for newly diagnosed myeloma patients undergoing stem cell transplant is an expected positive. Front line use is largely upside to ... |
